Pathologically, the high-risk group demonstrated significantly advanced T and N stages, increased tumor diameter, elevated Ki67 expression, a higher number of positive lymph nodes, and poorer tumor differentiation compared to the low-risk group (Figure 8). This evidence concerns the gene MKI67 and neoplasm.